Welcome to Seacross Pharmaceuticals Ltd.
Products
Oncology Injectable Other Product 1 Other Product 2
Docetaxel 20 mg/ml

Therapeutic indications: 

Docetaxel is used for the treatment of breast cancer, special forms of lung cancer (non-small cell lung cancer), prostate cancer, gastric cancer or head and neck cancer.

• For the treatment of advanced breast cancer, Docetaxel could be administered either alone or in combination with doxorubicin, or trastuzumab, or capecitabine.

• For the treatment of early breast cancer with or without lymph node involvement, Docetaxel could be administered in combination with doxorubicin and cyclophosphamide.

• For the treatment of lung cancer, Docetaxel could be administered either alone or in combination with cisplatin.

• For the treatment of prostate cancer, Docetaxel is administered in combination with prednisone or prednisolone.

• For the treatment of metastatic gastric cancer, Docetaxel is administered in combination with cisplatin and 5-fluorouracil.

• For the treatment of head and neck cancer, Docetaxel is administered in combination with cisplatin and 5-fluorouracil. 

Form Concentrate for solution for infusion
Strength 20mg/1ml, 80mg/4ml, 160mg/8ml
Active substance Docetaxel
Other ingredients Polysorbate 80, ethanol anhydrous and citric acid
© Copyright - Clinico fusce blandit sapien eu